[Federal Register Volume 74, Number 67 (Thursday, April 9, 2009)]
[Notices]
[Page 16235]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-8089]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated November 26, 2008 and published in the Federal 
Register on December 5, 2008, (73 FR 74095), GE Healthcare, 3350 North 
Ridge Avenue, Arlington Heights, Illinois 60004-1412, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of Cocaine (9041), a basic class of 
controlled substance listed in schedule II.
    The company plans to manufacture a radioactive product used in 
diagnostic imaging in the diagnosis of Parkinson's Disease and for 
manufacture in bulk for investigational new drug (IND) submission and 
clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
GE Healthcare to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated GE Healthcare to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic class of controlled substance listed.

    Dated: April 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E9-8089 Filed 4-8-09; 8:45 am]
BILLING CODE 4410-09-P